BriaCell reports extended survival in metastatic breast cancer trial
Tweet Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) announced that 9 of 25 patients treated with its Bria-IMT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


